Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report
Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency ane...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology
2019-01-01
|
Series: | Obstetrics & Gynecology Science |
Subjects: | |
Online Access: | http://ogscience.org/upload/pdf/ogs-62-69.pdf |
id |
doaj-aec983ee10904486b96901f4e6eb9fba |
---|---|
record_format |
Article |
spelling |
doaj-aec983ee10904486b96901f4e6eb9fba2020-11-25T03:52:33ZengKorean Society of Obstetrics and GynecologyObstetrics & Gynecology Science2287-85722287-85802019-01-01621697210.5468/ogs.2019.62.1.69622Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case reportMinhee Lee0Tae Hee Kim1Se Jeong Kim2Byung Chul Jee3Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, .KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, .KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, .KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, .KoreaPosterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency anemia. Brain magnetic resonance imaging showed high signal lesions in both occipital lobes on fluid-attenuated inversion-recovery (FLAIR) images, compatible with PRES. After treatment with anticonvulsant, she recovered both radiographically and clinically. The association between PRES and GnRH agonist use is still enigmatic, and thus should be further clarified.http://ogscience.org/upload/pdf/ogs-62-69.pdfgonadotropin-releasing hormoneleuprolidebrain diseasesmyoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Minhee Lee Tae Hee Kim Se Jeong Kim Byung Chul Jee |
spellingShingle |
Minhee Lee Tae Hee Kim Se Jeong Kim Byung Chul Jee Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report Obstetrics & Gynecology Science gonadotropin-releasing hormone leuprolide brain diseases myoma |
author_facet |
Minhee Lee Tae Hee Kim Se Jeong Kim Byung Chul Jee |
author_sort |
Minhee Lee |
title |
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
title_short |
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
title_full |
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
title_fullStr |
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
title_full_unstemmed |
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
title_sort |
posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
publisher |
Korean Society of Obstetrics and Gynecology |
series |
Obstetrics & Gynecology Science |
issn |
2287-8572 2287-8580 |
publishDate |
2019-01-01 |
description |
Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency anemia. Brain magnetic resonance imaging showed high signal lesions in both occipital lobes on fluid-attenuated inversion-recovery (FLAIR) images, compatible with PRES. After treatment with anticonvulsant, she recovered both radiographically and clinically. The association between PRES and GnRH agonist use is still enigmatic, and thus should be further clarified. |
topic |
gonadotropin-releasing hormone leuprolide brain diseases myoma |
url |
http://ogscience.org/upload/pdf/ogs-62-69.pdf |
work_keys_str_mv |
AT minheelee posteriorreversibleencephalopathysyndromeinawomanwhousedgonadotropinreleasinghormoneagonistsacasereport AT taeheekim posteriorreversibleencephalopathysyndromeinawomanwhousedgonadotropinreleasinghormoneagonistsacasereport AT sejeongkim posteriorreversibleencephalopathysyndromeinawomanwhousedgonadotropinreleasinghormoneagonistsacasereport AT byungchuljee posteriorreversibleencephalopathysyndromeinawomanwhousedgonadotropinreleasinghormoneagonistsacasereport |
_version_ |
1724482178281111552 |